Which has grown faster, BBIO or EHC?

Over the past five years, BBIO grew revenue faster — BBIO at a 62.61% CAGR versus EHC at 4.81%.

Does BBIO or EHC pay a bigger dividend?

EHC pays a dividend (0.63% yield), while BBIO has no payments in the available dividend history.

Is BBIO or EHC more profitable?

EHC runs the higher net margin — BBIO at -97.64% versus EHC at 10.01%.

How have BBIO and EHC total returns compared?

Over the past 5 years, BBIO delivered 7.38% and EHC delivered 17.12% annualized total return. Past performance doesn't predict future results.

BridgeBio Pharma, Inc. (BBIO) vs Encompass Health Corporation (EHC)

A side-by-side comparison of BridgeBio Pharma, Inc. and Encompass Health Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BBIO

BridgeBio Pharma, Inc.

$12.95B

$66.14HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

EHC

Encompass Health Corporation

$12.00B

$120.97HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT

Total return — BBIO vs EHC

growth of $100 · dividends reinvested · last 7y

BBIO +140.1% (+13.3%/yr)EHC +167.2% (+15.1%/yr)EHC compounded faster over this window

BBIO EHC

BBIO vs EHC: by the numbers

•BBIO is the larger company ($12.95B vs $12.00B market cap).
•EHC is profitable (10.01% net margin) while BBIO runs a net loss (-97.64%).
•BBIO grew revenue faster over the past five years (62.61% vs 4.81% CAGR).
•EHC pays a dividend (0.63% yield), while BBIO has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	BBIO	EHC
P/E ratio	N/A	19.70
Forward P/E	N/A	19.79
PEG ratio	N/A	1.39
P/S ratio	18.17	1.93
P/B ratio	N/A	4.62
EV / EBITDA	N/A	10.07
FCF yield	N/A	3.44%

Profitability

Metric	BBIO	EHC
Gross margin	93.35%	95.71%
Operating margin	-113.35%	18.00%
Net margin	-97.64%	10.01%
ROE	N/A	23.91%
ROIC	-62.14%	13.42%

Dividends

Metric	BBIO	EHC
Dividend yield	N/A	0.63%
Payout ratio	N/A	12.38%

Growth (annualized)

Metric	BBIO	EHC
Revenue CAGR (5Y)	62.61%	4.81%
EPS CAGR (5Y)	N/A	14.39%
FCF CAGR (5Y)	N/A	0.28%
Total return CAGR (5Y)	7.38%	17.12%

Frequently asked

Which has grown faster, BBIO or EHC?: Over the past five years, BBIO grew revenue faster — BBIO at a 62.61% CAGR versus EHC at 4.81%.
Does BBIO or EHC pay a bigger dividend?: EHC pays a dividend (0.63% yield), while BBIO has no payments in the available dividend history.
Is BBIO or EHC more profitable?: EHC runs the higher net margin — BBIO at -97.64% versus EHC at 10.01%.
How have BBIO and EHC total returns compared?: Over the past 5 years, BBIO delivered 7.38% and EHC delivered 17.12% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BBIO analysis Full EHC analysis Interactive comparison tool

Dig into the metrics

Encompass Health P/E ratio Encompass Health dividend yield BridgeBio Pharma ROE Encompass Health ROE BridgeBio Pharma operating margin Encompass Health operating margin BridgeBio Pharma revenue growth Encompass Health revenue growth BridgeBio Pharma free cash flow Encompass Health free cash flow

BridgeBio Pharma & Encompass Health appear in these rankings

Fastest Revenue Growth Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.